You finally find a supplement that checks every box. The ingredient list is solid, the dose is clinically relevant, the research is real. Then, three weeks in, you stop taking it. Not because it stopped working. Because you got tired of choking down four large capsules every morning with a full glass of water.
That scenario plays out millions of times a year, and a growing body of industry research is starting to treat it as the central problem in supplementation. Not efficacy. Not safety. Format fatigue.
Boredom Is Beating Skepticism
Glanbia Nutritionals, one of the largest ingredient suppliers in the global supplement industry, recently published research under its Designing Smarter Supplementation campaign. The findings are striking: among Gen Z and Millennial consumers, the primary reason for dropping a supplement routine isn't doubt about whether the ingredient works. It's boredom with the format they're taking it in.
That's a meaningful reframe. The industry has spent decades defending ingredient science, funding clinical trials, and responding to skeptics. Meanwhile, the actual dropout driver was sitting in the delivery mechanism the whole time.
Glanbia's data lands inside a market that's already under structural pressure to evolve. As we've covered in detail looking at FDA's New Dietary Ingredient Guidance: What It Changes for You, regulatory scrutiny is increasing at exactly the moment that consumer expectations around experience and convenience are rising. Manufacturers are being squeezed from both ends.
Gummies Won. Now Comes the Hard Part.
Gummies and chews have already won the shelf war in several categories. In the US market, gummy vitamins now outsell traditional pills across vitamin C, vitamin D, and multivitamin segments. The format shift is not a trend. It's a structural realignment.
But the commercial victory created a technical problem that the industry is still working through. Gummies are, at their core, a confection. They require sugar or sugar alcohols, gelatin or pectin, moisture, and heat during manufacturing. Each of those variables interacts badly with certain nutrients.
Here's the short list of what gets complicated:
- Omega-3 fatty acids are highly susceptible to oxidation. The heat and moisture exposure in gummy production accelerates rancidity, reducing potency and creating off-flavors that defeat the purpose of a taste-forward format.
- Probiotics are live organisms. Gummy matrices don't maintain the low water activity or cool temperatures that keep colony counts stable through a product's shelf life.
- Fat-soluble vitamins like K2 and D3 can be incorporated into gummies, but dosing precision is harder to guarantee when you're working inside a sugar-based matrix that varies slightly in weight from unit to unit.
- Iron is notoriously difficult to mask. At effective doses, it produces metallic off-notes that no amount of fruit flavoring fully covers, which is why most iron supplements remain in pill form.
The result is a market full of gummies that are genuinely enjoyable to take but frequently underdosed relative to what the label implies, or dosed correctly but degraded by the time they reach the consumer.
The Real Efficacy Variable Is Adherence
There's a principle worth stating plainly: a perfect supplement taken inconsistently produces worse outcomes than a mediocre supplement taken every day.
This is well-established in pharmacology and increasingly accepted in nutrition science. Bioavailability gets enormous attention. Dose-response curves get published. What rarely gets the same rigor is adherence modeling. How often are people actually taking the product, in the real world, over six or twelve months?
Glanbia's research suggests that format preference is a stronger predictor of long-term adherence than ingredient conviction. Meaning: you're more likely to stay consistent with a supplement you enjoy taking than one you intellectually agree with but dread consuming.
That finding connects directly to how we think about supplementation across complex wellness protocols. In our coverage of Supplements and HRT: What Helps vs. What Interferes, one recurring theme is that the supplements most likely to support hormonal health are ones taken consistently over months. A magnesium gummy that someone actually takes nightly outperforms a superior magnesium glycinate capsule that gets abandoned by week four.
Format is a compliance tool. The industry is only now starting to engineer for that explicitly.
Taste-First Delivery and the Dose Problem
The challenge manufacturers face is threading a specific needle: making a product enjoyable enough to drive consistent use, without compromising the dose enough to make it clinically irrelevant.
Taste masking is a legitimate science. Encapsulation technologies, flavor pairings, and matrix engineering can all reduce bitterness, metallic notes, and fishy oxidation signatures. Some of these approaches work well. Others add cost or introduce stability variables of their own.
The dosing problem is more stubborn. A standard gummy weighs between 3 and 5 grams. When you're working with a nutrient that needs to be present at, say, 500mg per serving, you're already eating up a significant fraction of that matrix with the active ingredient before you've added any of the structural components that make it a gummy. Scale that to two or three gummies per serving, and you're back to the same inconvenience problem you were trying to escape.
Chews, strips, and functional beverages offer more flexibility on volume, but each format carries its own stability and palatability tradeoffs. There's no format that solves everything simultaneously, which is why the more honest manufacturers are increasingly upfront about which nutrients their delivery system handles well and which it doesn't.
The $244 Billion Pressure Test
The global supplement market is now valued at over $244 billion, and a meaningful share of that growth is being driven by consumers who are first-time supplement users or who have lapsed and returned. Both groups share a common profile: they're not primarily motivated by clinical literature. They're motivated by ease, habit integration, and sensory experience.
That consumer profile is reshaping product development priorities. R&D investment is increasingly flowing toward delivery innovation rather than ingredient novelty. The question isn't just "does this nutrient work?" It's "will someone actually keep taking this?"
The science of exercise gives a useful parallel here. Research published on how exercise changes your body at a molecular level shows that consistency of training stimulus matters enormously for downstream physiological outcomes. The same logic applies to supplementation. Intermittent exposure to even a well-formulated product doesn't move the needle the way daily, sustained intake does.
What This Means for How You Choose Supplements
If format adherence is the limiting variable, then choosing a supplement based purely on ingredient quality is an incomplete strategy. Here's how to think about it more completely:
- Audit your actual behavior, not your intentions. If you've abandoned pill-based supplements before, that's a signal. Don't assume discipline will solve a format mismatch.
- Match format to context. A gummy or chew you take as part of a morning food routine is more likely to stick than a capsule that requires a separate glass of water and a separate mental step.
- Check the dose math. For nutrients where effective doses are well-established, verify the serving size on a gummy product delivers what it claims. Independent third-party testing certifications from organizations like NSF International or USP are your best filter here.
- Respect the chemistry limits. For omega-3s and probiotics specifically, current gummy technology rarely delivers on the same terms as a well-made softgel or enteric-coated capsule. The format preference tradeoff may not be worth it for those specific nutrients.
- Treat consistency as the primary outcome metric. A supplement protocol you maintain for six months will outperform a theoretically superior one you abandon at week five.
Format as a Design Problem, Not a Marketing Problem
The most important shift in Glanbia's framing is treating format as a design problem rather than a marketing one. For years, the supplement industry leaned on flavor and packaging to differentiate at the shelf without necessarily solving the underlying experience. A gummy that tastes better than a competitor's gummy but delivers half the active dose isn't a solution. It's a lateral move.
Genuine progress looks like encapsulation systems that protect heat-sensitive ingredients through processing, precision dosing that accounts for matrix variability, and shelf-life data that actually tracks potency at end of shelf life rather than at manufacture.
The good news is that ingredient suppliers and manufacturers are starting to invest here in meaningful ways. The category is maturing past the first wave of gummy enthusiasm into a second wave where the technical infrastructure has to catch up with the consumer expectation.
You're the beneficiary of that maturation, but only if you're asking the right questions at the point of purchase. Format matters. So does what's inside it. The best products are the ones where those two things are finally being engineered together.